|
Rodriguez-Gomez I, Wangensteen R, Atucha NM, O'Valle F, Del Moral RG, Garcia-Estañ J, Vargas F, Osuna A. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats. Am J Hypertens. 2003 Jan;16(1):33-8. PubMed PMID: 12517680.
AÑO: 2003; IF: 3.103
|
12517680
|
Fortepiani LA, Ortíz MC, Atucha NM, García-Estañ J. Nebivolol ameliorates nitric oxide deficient hypertension. ScientificWorldJournal. 2002 Jun 20;2:1676-84. PubMed PMID: 12806161.
AÑO: 2002; IF: 1.73
|
|
Ortiz MC, Fortepiani LA, Martínez-Salgado C, Eleno N, Atucha NM, López-Novoa JM, García-Estañ J. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites]. Nefrologia. 2001;21(6):556-64. Spanish. PubMed PMID: 11881425.
AÑO: 2001; IF: 0.513
|
|
Morazo P, Fortepiani LA, Clara Ortíz M, Atucha NM, García-Estañ J. Omapatrilat normalizes renal function curve in spontaneously hypertensive rats. BMC Pharmacol. 2001;1:5. Epub 2001 Sep 11. PubMed PMID: 11592920; PubMed Central PMCID: PMC57752.
AÑO: 2001
|
|
Ruiz-Marcos FM, Ortíz MC, Fortepiani LA, Nadal FJ, Atucha NM, García-Estañ J. Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats. Eur J Pharmacol. 2001 Feb 2;412(3):273-9. PubMed PMID: 11166291.
AÑO: 2001; IF: 2.342
|